Breaking News

Jabil Acquires Pii

Enhances its existing pharmaceutical solutions, enabling comprehensive support for customers in drug development, clinical trials, and product commercialization at scale.

Author Image

By: Charlie Sternberg

Associate Editor

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in early-stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid dose manufacturing. “As the pace of healthcare innovation accelerates, pharmaceutical companies need partners who can help them scale rapidly with a focus on quality and safety. Jabil and Pii’...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters